ClinConnect ClinConnect Logo
Search / Trial NCT06038019

Thresholds In Food Allergy evaluaTion And predictioN

Launched by HAMILTON HEALTH SCIENCES CORPORATION · Sep 7, 2023

Trial Information

Current as of September 01, 2025

Recruiting

Keywords

Immunotherapy Food Allergy Diagnosis Prognosis

ClinConnect Summary

The clinical trial titled "Thresholds In Food Allergy evaluaTion And predictioN" is looking to better understand food allergy thresholds, specifically for tree nut allergies in Canada. Researchers want to find out how much of a food allergen a person can tolerate before experiencing allergic reactions. This study is currently recruiting participants of all ages, from infants to adults, who have a suspected or confirmed food allergy based on their medical history and allergy tests.

To be eligible for the study, participants should have a history of food allergy symptoms, such as hives, swelling, or stomach issues, occurring within an hour after eating a specific food. They will need to stop taking antihistamines, which are medications that treat allergy symptoms, for a week before participating in an oral food challenge. However, individuals who have had prior desensitization treatments, have serious health issues, or allergies to any part of the test food will not be able to join. Participants can expect to help researchers learn more about food allergies, which may lead to better management and treatment options in the future.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • 1. Suspicion or history of food allergy based on medical history, positive skin prick test, and/or serum food-specific IgE. A suggestive history is defined as typical clinical signs and/or symptoms (urticaria, angioedema, abdominal pain, vomiting, dyspnea, wheeze) within 60 minutes of the ingestion of a food.
  • 2. Ability to discontinue all antihistamines for 1 week before oral food challenge.
  • Exclusion Criteria:
  • 1. Previous desensitization treatment to a food allergen
  • 2. Allergies to any component of the oral challenge vehicle
  • 3. Unstable conditions including uncontrolled asthma or chronic urticaria
  • 4. Any clinically significant disease/chronic medical condition which may interfere with study evaluations.

About Hamilton Health Sciences Corporation

Hamilton Health Sciences Corporation is a leading healthcare provider in Canada, renowned for its commitment to advancing medical research and improving patient care through innovative clinical trials. With a focus on translating scientific discoveries into effective treatments, the organization operates a network of hospitals and specialized centers that facilitate cutting-edge research across various medical disciplines. Hamilton Health Sciences is dedicated to fostering collaboration among researchers, healthcare professionals, and industry partners, ensuring that clinical trials are conducted with the highest ethical standards and rigor. Through its robust research infrastructure, the corporation aims to enhance health outcomes and contribute to the global body of medical knowledge.

Locations

Hamilton, Ontario, Canada

Patients applied

0 patients applied

Trial Officials

Derek Chu, MD PhD FRCPC

Principal Investigator

Hamilton Health Sciences & McMaster University

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported